Get it on Google Play

Intelligent Bio Solutions completes usability study for FDA submission

August 5, 2026 8:30 AM EDT Send to a Friend
Intelligent Bio Solutions Inc. (NASDAQ: INBS) announced the completion of a usability study for its Intelligent Fingerprinting Drug Screening System ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login